SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-144237
Filing Date
2019-05-10
Accepted
2019-05-10 16:07:24
Documents
82
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d715476d10q.htm 10-Q 498286
2 EX-31.1 d715476dex311.htm EX-31.1 10618
3 EX-31.2 d715476dex312.htm EX-31.2 10575
4 EX-32.1 d715476dex321.htm EX-32.1 3517
5 EX-32.2 d715476dex322.htm EX-32.2 3478
  Complete submission text file 0001193125-19-144237.txt   7284963

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eypt-20190331.xml EX-101.INS 1970605
7 XBRL TAXONOMY EXTENSION SCHEMA eypt-20190331.xsd EX-101.SCH 79101
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20190331_cal.xml EX-101.CAL 41375
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20190331_def.xml EX-101.DEF 366342
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20190331_lab.xml EX-101.LAB 544750
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20190331_pre.xml EX-101.PRE 476687
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 19814923
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10